Shapiro CL - Search Results

1

Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?

Woodard S, Nadella PC, Kotur L, Wilson J, Burak WE, Shapiro CL. Woodard S, et al. Among authors: shapiro cl. Cancer. 2003 Sep 15;98(6):1141-9. doi: 10.1002/cncr.11640. Cancer. 2003. PMID: 12973837 Free article.

2

Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.

Shapiro CL, Gelman RS, Hayes DF, Osteen R, Obando A, Canellos GP, Frei E 3rd, Henderson IC. Shapiro CL, et al. J Natl Cancer Inst. 1993 May 19;85(10):812-7. doi: 10.1093/jnci/85.10.812. J Natl Cancer Inst. 1993. PMID: 8487326 Clinical Trial.

3

The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?

Guadagnoli E, Shapiro CL, Weeks JC, Gurwitz JH, Borbas C, Soumerai SB. Guadagnoli E, et al. Among authors: shapiro cl. Cancer. 1998 Jul 15;83(2):302-9. Cancer. 1998. PMID: 9669813

4

Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patients.

Shapiro CL, Keating J, Angell JE, Janicek M, Gelman R, Hayes D, LeBoff MS. Shapiro CL, et al. Cancer Invest. 1999;17(8):566-74. doi: 10.3109/07357909909032841. Cancer Invest. 1999. PMID: 10592763

5

Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.

Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD. Jacobson AF, et al. Among authors: shapiro cl. Cancer. 2001 Jan 1;91(1):17-24. doi: 10.1002/1097-0142(20010101)91:1<17::aid-cncr3>3.0.co;2-k. Cancer. 2001. PMID: 11148555

6

Side effects of adjuvant treatment of breast cancer.

Shapiro CL, Recht A. Shapiro CL, et al. N Engl J Med. 2001 Jun 28;344(26):1997-2008. doi: 10.1056/NEJM200106283442607. N Engl J Med. 2001. PMID: 11430330 Review. No abstract available.

7

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.

Shapiro CL, Manola J, Leboff M. Shapiro CL, et al. J Clin Oncol. 2001 Jul 15;19(14):3306-11. doi: 10.1200/JCO.2001.19.14.3306. J Clin Oncol. 2001. PMID: 11454877

8

Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.

Nadella P, Shapiro C, Otterson GA, Hauger M, Erdal S, Kraut E, Clinton S, Shah M, Stanek M, Monk P, Villalona-Calero MA. Nadella P, et al. J Clin Oncol. 2002 Jun 1;20(11):2616-23. doi: 10.1200/JCO.2002.22.030. J Clin Oncol. 2002. PMID: 12039922 Clinical Trial.

9

Rationale for mitomycin and irinotecan use in advanced breast cancer.

Xu Y, Shapiro CL. Xu Y, et al. Among authors: shapiro cl. Oncology (Williston Park). 2003 May;17(5 Suppl 5):25-8. Oncology (Williston Park). 2003. PMID: 12800602 Review.

10

Phase II trial of bevacizumab in combination with docetaxel in women with advanced breast cancer.

Ramaswamy B, Shapiro CL. Ramaswamy B, et al. Among authors: shapiro cl. Clin Breast Cancer. 2003 Oct;4(4):292-4. doi: 10.3816/cbc.2003.n.035. Clin Breast Cancer. 2003. PMID: 14651775 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters